Proteome analysis of butyrate‐treated human colon cancer cells (HT‐29)

Butyrate, a 4‐carbon fatty acid, has been shown to cause growth arrest and apoptosis of cancer cells in vitro and in vivo. The signaling pathways leading to changes in cell growth are unclear. We used a functional proteomics approach to delineate the pathways and mediators involved in butyrate actio...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer 2002-04, Vol.98 (4), p.523-531
Main Authors: Tan, Sandra, Seow, Teck Keong, Liang, Rosa Cynthia M.Y., Koh, Shiuan, Lee, Christine P.C., Chung, Maxey C.M., Hooi, Shing Chuan
Format: Article
Language:English
Subjects:
2‐D gel electrophoresis
Biological and medical sciences
butyrate
Butyrates - pharmacology
colon cancer
Electrophoresis, Gel, Two-Dimensional
Gastroenterology. Liver. Pancreas. Abdomen
HT29 Cells - drug effects
HT29 Cells - metabolism
Humans
MALDI‐TOF mass spectrometry
Medical sciences
Proteome - analysis
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Tumor Cells, Cultured - drug effects
Tumor Cells, Cultured - metabolism
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Butyrate, a 4‐carbon fatty acid, has been shown to cause growth arrest and apoptosis of cancer cells in vitro and in vivo. The signaling pathways leading to changes in cell growth are unclear. We used a functional proteomics approach to delineate the pathways and mediators involved in butyrate action in HT‐29 cells at 24 hr posttreatment. Using 2‐dimensional gel electrophoresis, we showed that butyrate treatment resulted in alterations in the proteome of HT‐29 cells. MALDI‐TOF mass spectrometry was used to identify butyrate‐regulated spots. First, our results revealed that the expression of various components of the ubiquitin‐proteasome system was altered with butyrate treatment. This suggests that, in addition to the regulation of gene expression through the histone deacetylase pathway, proteolysis could be a means by which butyrate may regulate the expression of key proteins in the control of cell cycle, apoptosis and differentiation. Second, we found that both proapoptotic proteins (capase‐4 and cathepsin D) and antiapoptotic proteins (hsp27, antioxidant protein‐2 and pyruvate dehydrogenase E1) were simultaneously upregulated in butyrate‐treated cells. Western blotting was carried out to confirm butyrate regulation of the spots. Both cathepsin D and hsp27 showed a time‐dependent increase in expression with butyrate treatment in HT‐29 cells. However, in HCT‐116 cells, which were 5‐fold more sensitive to butyrate‐induced apoptosis, the upregulation of cathepsin D with time was not accompanied by a similar increase in hsp27 levels. Thus, the simultaneous upregulation of both proapoptotic and antiapoptotic proteins in HT‐29 cells may account for their relative resistance to butyrate‐induced apoptosis. © 2002 Wiley‐Liss, Inc.
ISSN:0020-7136
1097-0215
DOI:10.1002/ijc.10236